2 Scope of Report Product of Interest (POI): Head and Neck Cancer Therapeutics Review Period 2017 – 2020 Base Year 2021 Estimated Year 2022 Forecast Period 2023 – 2027 Year Range DIAGNOSTIC METHODS REGION • North America • Europe • APAC • South America • Middle East & Africa • Biopsy • Imaging • Endoscopy • Others Head and neck cancer is a term used to define cancer that develops in the mouth, throat, nose, salivary glands, oral cancers or other areas of the head and neck . Most of these cancers are squamous cell carcinomas, or cancers that begin in the lining of the mouth, nose and throat . Market Segmentation DISEASE INDICATION • Lip and Oral Cavity Cancer • Laryngeal Cancer • Oropharyngeal Cancer • Salivary Gland Cancer • Nasopharyngeal Cancer • Hypopharyngeal Cancer • Surgery • Radiation Therapy • Chemotherapy • Immunotherapy • Targeted Therapy TREATMENT TYPE ROUTE OF ADMINISTRATION THERAPEUTIC CLASS END USER • Injectable • Oral • PD Inhibitors • EGFR Inhibitors • Microtubule Inhibitors • Hospitals • Specialty Clinics • Ambulatory Surgical Centers • Others